• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二肽基肽酶IV作为一种肌肉肌动蛋白

Dipeptidyl Peptidase IV as a Muscle Myokine.

作者信息

Kluess Heidi A

机构信息

School of Kinesiology, Auburn University, Auburn, AL, United States.

出版信息

Front Physiol. 2020 Mar 3;11:148. doi: 10.3389/fphys.2020.00148. eCollection 2020.

DOI:10.3389/fphys.2020.00148
PMID:32194435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7063094/
Abstract

Dipeptidyl peptidase IV (DPP-IV) is a unique serine protease that exists in a membrane bound state and in a soluble state in most tissues in the body. DPP-IV has multiple targets including cytokines, neuropeptides, and incretin hormones, and plays an important role in health and disease. Recent work suggests that skeletal muscle releases DPP-IV as a myokine and participates in control of muscle blood flow. However, few of the functions of DPP-IV as a myokine have been investigated to date and there is a poor understanding about what causes DPP-IV to be released from muscle.

摘要

二肽基肽酶IV(DPP-IV)是一种独特的丝氨酸蛋白酶,在体内大多数组织中以膜结合状态和可溶性状态存在。DPP-IV有多个靶点,包括细胞因子、神经肽和肠促胰岛素激素,在健康和疾病中发挥重要作用。最近的研究表明,骨骼肌会释放DPP-IV作为一种肌动蛋白,并参与肌肉血流的控制。然而,迄今为止,作为肌动蛋白的DPP-IV的功能很少被研究,人们对导致DPP-IV从肌肉中释放的原因也知之甚少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b114/7063094/6024535f3312/fphys-11-00148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b114/7063094/6024535f3312/fphys-11-00148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b114/7063094/6024535f3312/fphys-11-00148-g001.jpg

相似文献

1
Dipeptidyl Peptidase IV as a Muscle Myokine.二肽基肽酶IV作为一种肌肉肌动蛋白
Front Physiol. 2020 Mar 3;11:148. doi: 10.3389/fphys.2020.00148. eCollection 2020.
2
The serine protease, dipeptidyl peptidase IV as a myokine: dietary protein and exercise mimetics as a stimulus for transcription and release.丝氨酸蛋白酶二肽基肽酶IV作为一种肌动蛋白:膳食蛋白质和运动模拟物作为转录和释放的刺激因素。
Physiol Rep. 2016 Jun;4(12). doi: 10.14814/phy2.12827.
3
Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.内源性二肽基肽酶IV调节大鼠骨骼肌小动脉直径。
Physiol Rep. 2018 Jan;6(2). doi: 10.14814/phy2.13564.
4
The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.二肽基肽酶IV(DPP IV / CD26)的独特性质及DPP IV抑制剂的治疗潜力。
Curr Med Chem. 1999 Apr;6(4):311-27.
5
Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?二肽基肽酶 IV 及其抑制剂:用于 2 型糖尿病的治疗药物及其它用途
J Med Chem. 2014 Mar 27;57(6):2197-212. doi: 10.1021/jm400658e. Epub 2013 Oct 24.
6
Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.用于糖尿病治疗的基于合成化合物和植物化合物的二肽基肽酶-IV(DPP-IV)抑制剂
J Asian Nat Prod Res. 2017 Oct;19(10):1036-1045. doi: 10.1080/10286020.2017.1307183. Epub 2017 Mar 29.
7
Dipeptidyl peptidase IV (DPP-IV) inhibitory properties of a camel whey protein enriched hydrolysate preparation.富含骆驼乳清蛋白水解物的二肽基肽酶 IV(DPP-IV)抑制特性。
Food Chem. 2019 May 1;279:70-79. doi: 10.1016/j.foodchem.2018.11.142. Epub 2018 Dec 5.
8
Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.膳食蛋白来源的二肽基肽酶 IV(DPP-IV)抑制肽的特点。
J Food Biochem. 2019 Jan;43(1):e12451. doi: 10.1111/jfbc.12451. Epub 2017 Nov 1.
9
Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes.二肽基肽酶抑制剂作为治疗2型糖尿病的新药。
Diabetologia. 2005 Apr;48(4):616-20. doi: 10.1007/s00125-005-1707-5. Epub 2005 Mar 16.
10
Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV.人二肽基肽酶IV的新型同源物——人DPP9的鉴定与特性分析
Gene. 2002 Oct 16;299(1-2):185-93. doi: 10.1016/s0378-1119(02)01059-4.

引用本文的文献

1
Combined training and hormones/enzymes with insulinotropic actions in individuals with overweight and type 2 diabetes mellitus: A randomized controlled trial.超重和2型糖尿病患者联合训练与具有促胰岛素分泌作用的激素/酶:一项随机对照试验
Eur J Sport Sci. 2024 Jan;24(1):97-106. doi: 10.1002/ejsc.12057.
2
Myokines: Novel therapeutic targets for diabetic nephropathy.肌因子:糖尿病肾病的新型治疗靶点。
Front Endocrinol (Lausanne). 2022 Oct 25;13:1014581. doi: 10.3389/fendo.2022.1014581. eCollection 2022.
3
A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes.

本文引用的文献

1
Dipeptidyl peptidase-4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats.二肽基肽酶-4抑制剂与有氧运动协同保护去卵巢大鼠免受肝损伤。
Physiol Rep. 2019 Sep;7(17):e14191. doi: 10.14814/phy2.14191.
2
Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice.二肽基肽酶-4抑制剂与运动训练联合治疗可改善KK/Ta小鼠的血脂水平。
Exp Physiol. 2019 Jul;104(7):1051-1060. doi: 10.1113/EP087449. Epub 2019 May 22.
3
Neuropeptide Y and dipeptidyl peptidase IV in normally cycling and postmenopausal women: A prospective pilot study.
作为二肽基肽酶-4抑制剂用于糖尿病管理的天然来源的综合综述与展望
Pharmaceuticals (Basel). 2021 Jun 20;14(6):591. doi: 10.3390/ph14060591.
正常月经周期和绝经后女性体内的神经肽Y和二肽基肽酶IV:一项前瞻性初步研究。
Medicine (Baltimore). 2019 Mar;98(13):e14982. doi: 10.1097/MD.0000000000014982.
4
Prevention of Heart Failure in Patients with Diabetes: Role of Diabetes Medications.预防糖尿病患者心力衰竭:糖尿病药物的作用。
Curr Cardiol Rep. 2018 Sep 26;20(11):112. doi: 10.1007/s11886-018-1050-3.
5
Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.内源性二肽基肽酶IV调节大鼠骨骼肌小动脉直径。
Physiol Rep. 2018 Jan;6(2). doi: 10.14814/phy2.13564.
6
Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction.射血分数降低的慢性心力衰竭中的二肽基肽酶-IV
Int J Cardiol. 2017 Aug 15;241:249-254. doi: 10.1016/j.ijcard.2017.03.042. Epub 2017 Mar 11.
7
Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling.二肽基肽酶-4 抑制剂通过激活胰高血糖素样肽-1 受体信号改善心力衰竭小鼠的运动能力和线粒体生物发生。
Cardiovasc Res. 2016 Sep;111(4):338-47. doi: 10.1093/cvr/cvw182. Epub 2016 Jul 21.
8
Plasma dipeptidyl peptidase IV activity and measures of body composition in apparently healthy people.在貌似健康的人群中,血浆二肽基肽酶 IV 活性与身体成分测量。
Heliyon. 2016 Apr 18;2(4):e00097. doi: 10.1016/j.heliyon.2016.e00097. eCollection 2016 Apr.
9
The serine protease, dipeptidyl peptidase IV as a myokine: dietary protein and exercise mimetics as a stimulus for transcription and release.丝氨酸蛋白酶二肽基肽酶IV作为一种肌动蛋白:膳食蛋白质和运动模拟物作为转录和释放的刺激因素。
Physiol Rep. 2016 Jun;4(12). doi: 10.14814/phy2.12827.
10
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.切入正题:关于CD26/二肽基肽酶4(DPP4)在免疫系统中相互关系的综述
Clin Exp Immunol. 2016 Jul;185(1):1-21. doi: 10.1111/cei.12781. Epub 2016 May 13.